載入...
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guide...
Na minha lista:
| 發表在: | Chin J Traumatol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5343095/ https://ncbi.nlm.nih.gov/pubmed/28236566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjtee.2016.05.004 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|